Brought to you by 
Medtronic buys CryoCath for $361mm
25 Sep 2008
Executive Summary
Medtronic has agreed to acquire CryoCath Technologies (using cryotherapy devices to treat cardiac arrhythmias) for a total of about $361mm ($Cdn374mm) or $8.46 per share (a 93% premium).
Deal Industry
- Medical Devices
-
Medical Devices
- Implantable Devices
-
Surgical Equipment & Devices
- Minimally or Less Invasive
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
- Payment Includes Cash
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com